{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:47:51Z","timestamp":1792316871563,"version":"4.4.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22C010004"],"award-info":[{"award-number":["LY22C010004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070162"],"award-info":[{"award-number":["32070162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870159"],"award-info":[{"award-number":["31870159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2022J131"],"award-info":[{"award-number":["2022J131"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Japanese encephalitis virus (JEV) and Zika virus (ZIKV) pose a severe threat to human health. Our previous research results, as well as those of other research groups, indicated that antibodies (Abs) induced by JEV infection or JEV vaccine vaccination could enhance ZIKV infection <jats:italic>in vitro<\/jats:italic> and exacerbate the mortality of ZIKV-infected mice, vice versa, which is known as antibody-dependent enhancement (ADE). Although studies on other flaviviruses revealed that altering the amino acid residues located in the fusion loop (FL) of envelope (E) protein can reduce the level of flavivirus-cross-reactive Abs, thereby abating the ADE of heterologous flavivirus infection, it is unclear whether this strategy is equally applicable to JEV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we constructed recombinant adenoviruses and nucleotide-modified mRNA-lipid nanoparticle (LNP) encoding JEV wild-type E protein or E protein mutant (designated as Ad5-JEV-E<jats:sup>WT<\/jats:sup> and Ad5-JEV-E<jats:sup>mut<\/jats:sup>; JEV-E<jats:sup>WT<\/jats:sup> mRNA-LNP, and JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP). We evaluated the immunogenicity of these vaccine candidates in mice and the capacity of vaccine-immune mouse sera to neutralize JEV infection or mediate ADE of ZIKV infection <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ad5-JEV-E<jats:sup>mut<\/jats:sup> or JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP immunization induced ZIKV-cross-reactive Ab response which is dramatically lower than that induced by Ad5-JEV-E<jats:sup>WT<\/jats:sup> and JEV-E<jats:sup>WT<\/jats:sup> mRNA-LNP, respectively. The levels of JEV-neutralizing Abs induced by Ad5-JEV-E<jats:sup>mut<\/jats:sup> or JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP are comparable to that induced by Ad5-JEV-E<jats:sup>WT<\/jats:sup> and JEV-E<jats:sup>WT<\/jats:sup> mRNA-LNP, respectively. The ability of Abs induced by Ad5-JEV-E<jats:sup>mut<\/jats:sup> to enhance ZIKV infection <jats:italic>in vitro<\/jats:italic> is attenuated as compared with that induced by Ad5-JEV-E<jats:sup>WT<\/jats:sup>. Moreover, JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP immunization elicited potent T cell response similar to JEV-E<jats:sup>WT<\/jats:sup> mRNA-LNP in mice. Mice immunized with each mRNA-LNP exhibited lower level of serum viral load than the mock-immunized mice post JEV challenge. Mice receiving JEV-E<jats:sup>WT<\/jats:sup> mRNA-LNP-immune mouse sera exhibited ADE post ZIKV challenge whereas passively transferred JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP-immune mouse sera did not lead to obvious ADE of ZIKV infection in recipient mice. Most importantly, maternally acquired Abs did not enhance the mortality of 1-day-old neonates born to JEV-E<jats:sup>mut<\/jats:sup> mRNA-LNP-immunized mice post ZIKV challenge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results suggest that optimizing the FL sequence of JEV could significantly reduce the level of JEV\/ZIKV-cross-reactive Abs and abrogate the ADE of ZIKV infection, providing a promising strategy to develop effective and safety JEV vaccine.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1472824","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:10:58Z","timestamp":1731305458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiayang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/cells8050507","article-title":"Heterologous immunity between adenoviruses and hepatitis C virus (HCV): recombinant adenovirus vaccine vectors containing antigens from unrelated pathogens induce cross-reactive immunity against HCV antigens","volume":"8","author":"Agrawal","year":"2019","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40794-015-0013-6","article-title":"Japanese encephalitis: a review of clinical guidelines and vaccine availability in Asia","volume":"1","author":"Batchelor","year":"2015","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/vaccines8040603","article-title":"A recombinant Zika virus envelope protein with mutations in the conserved fusion loop leads to reduced antibody cross-reactivity upon vaccination","volume":"8","author":"Berneck","year":"2020","journal-title":"Vaccines"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/v14081779","article-title":"Construction and evaluation of recombinant adenovirus candidate vaccines for chikungunya virus","volume":"14","author":"Cao","year":"2022","journal-title":"Viruses"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e20192152","DOI":"10.1084\/jem.20192152","article-title":"Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis","volume":"217","author":"Chen","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1128\/CVI.00004-08","article-title":"Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections","volume":"15","author":"Chiou","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1099\/vir.0.040238-0","article-title":"Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein","volume":"93","author":"Chiou","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1099\/vir.0.82640-0","article-title":"A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles","volume":"88","author":"Crill","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.15585\/mmwr.mm6534e1","article-title":"Guillain-Barr\u00e9 syndrome during ongoing Zika virus transmission\u2014Puerto Rico, January 1\u2013July 31, 2016","volume":"65","author":"Dirlikov","year":"2016","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/med.21891","article-title":"Natural products as Zika antivirals","volume":"42","author":"Fong","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature20556","article-title":"Zika virus infection damages the testes in mice","volume":"540","author":"Govero","year":"2016","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12879-018-3572-0","article-title":"Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora\u2019s box?","volume":"18","author":"Gunawardana","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"ref18","first-page":"24","article-title":"Immunological enhancement of dengue virus replication","volume":"243","author":"Halstead","year":"","journal-title":"Nat. New Biol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"Halstead","year":"","journal-title":"J. Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00430-020-00658-2","article-title":"The effects of Japanese encephalitis virus antibodies on Zika virus infection","volume":"209","author":"He","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1586\/14787210.2014.929498","article-title":"Control of Japanese encephalitis in Asia: the time is now","volume":"12","author":"Hills","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/22221751.2021.1941276","article-title":"Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR)","volume":"10","author":"Huang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of action of mRNA-based vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/pharmaceutics13111826","article-title":"Immunological analysis of nodavirus capsid displaying the domain III of Japanese encephalitis virus envelope protein","volume":"13","author":"Kumar","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2451","DOI":"10.1371\/journal.pntd.0002451","article-title":"Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases","volume":"7","author":"Lai","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA vaccine to balance innate\/adaptive immune response","volume":"26","author":"Linares-Fernandez","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0008312","DOI":"10.1371\/journal.pntd.0008312","article-title":"An outbreak of Japanese encephalitis caused by genotype Ib Japanese encephalitis virus in China, 2018: a laboratory and field investigation","volume":"14","author":"Liu","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"100679","DOI":"10.1016\/j.xcrm.2022.100679","article-title":"Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant","volume":"3","author":"Lyke","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/pathogens9040247","article-title":"Non-human primate models of dengue virus infection: a comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys","volume":"9","author":"Muhammad Azami","year":"2020","journal-title":"Pathogens"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"O595","DOI":"10.1111\/1469-0691.12707","article-title":"Rapid spread of emerging Zika virus in the Pacific area","volume":"20","author":"Musso","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects\u2014reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e0004218","DOI":"10.1371\/journal.pntd.0004218","article-title":"Recombinant envelope-proteins with mutations in the conserved fusion loop allow specific serological diagnosis of dengue-infections","volume":"9","author":"Rockstroh","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJMe1601862","article-title":"Zika virus and microcephaly","volume":"374","author":"Rubin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm6503e2","article-title":"Possible association between Zika virus infection and microcephaly\u2014Brazil, 2015","volume":"65","author":"Schuler-Faccini","year":"2016","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100994","DOI":"10.1016\/j.mam.2021.100994","article-title":"Pathobiology of Japanese encephalitis virus infection","volume":"81","author":"Sharma","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/brain\/awf116","article-title":"Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis","volume":"125","author":"Solomon","year":"2002","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1007\/s00253-023-12817-5","article-title":"Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain","volume":"107","author":"Tabata","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection","volume":"87","author":"Tsai","year":"2013","journal-title":"J. Virol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fc\u03b3 receptor and complement-dependent effector mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J. Virol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"104476","DOI":"10.1016\/j.meegid.2020.104476","article-title":"Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting","volume":"85","author":"Wang","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000149642","article-title":"Flaviviridae","volume":"24","author":"Westaway","year":"1985","journal-title":"Intervirology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/v9110338","article-title":"Structures and functions of the envelope glycoprotein in flavivirus infections","volume":"9","author":"Zhang","year":"2017","journal-title":"Viruses"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.virol.2006.05.025","article-title":"A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus","volume":"353","author":"Zhang","year":"2006","journal-title":"Virology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.scib.2019.11.006","article-title":"The pre-existing cellular immunity to Japanese encephalitis virus heterotypically protects mice from Zika virus infection","volume":"65","author":"Zhang","year":"2020","journal-title":"Sci. Bull."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1472824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:11:01Z","timestamp":1731305461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1472824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":52,"alternative-id":["10.3389\/fmicb.2024.1472824"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1472824","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"article-number":"1472824"}}